SHAROKY MELVIN MD

SEC source: 0001140361-22-007950 · form4.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,976

F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

SEC source: 0001140361-22-007950 · form4.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 1,847

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

SEC source: 0001140361-22-007950 · form4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,976

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

SEC source: 0001140361-21-039388 · form4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,976

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to each of the following individuals: Jason Wink (son-in-law) and Pilee Sharoky (daughter-in-law), neither of whom share the Reporting Person's household.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 8

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,876

F5 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F6 · price: Each Restricted Stock Unit was granted on May 12, 2021 for no consideration.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 5

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Melvin Sharoky C/F Sophie C. Wink UTMA/FL

Disclosed balance after: 184

F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 4

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,318

F2 · kind: The reported transactions involved a gift of securities by the Reporting Person to an investment account, Melvin Sharoky C/F Sophie C. Wink UTMA/FL, for the benefit of the Reporting Person's granddaughter. The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By spouse

Disclosed balance after: 847

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,502

F1 · kind: The reported transactions involved a gift of securities by the Reporting Person to his spouse.

SEC source: 0001140361-21-017411 · form4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 230,349

SEC source: 0001104659-20-129005 · a4.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,890

F3 · price: This is the weighted average sales price representing 4,000 shares sold at prices ranging from $39.04 to $39.17 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

SEC source: 0001104659-20-129005 · a4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Baby Gator LLC

Disclosed balance after: 5,900

F1 · price: This is the weighted average sales price representing 4,000 shares sold at prices ranging from $38.92 to $39.05 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F2 · ownership.nature: The Reporting Person is a managing member of Baby Gator LLC.

SEC source: 0001104659-20-127949 · a4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by The Sharoky Family Foundation, Inc.

Disclosed balance after: 7,714

F1 · price: This is the weighted average sales price representing 4,000 shares sold at prices ranging from $39.42 to $39.53 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F2 · ownership.nature: The Reporting Person is Chairman of The Sharoky Family Foundation, Inc. and is one of three individuals who currently share voting and investment power over the shares held by The Sharoky Family Foundation, Inc. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-20-105778 · a4.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,890

F2 · price: This is the weighted average sales price representing 9,900 shares sold at prices ranging from $30.89 to $31.14 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

SEC source: 0001104659-20-105778 · a4.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Baby Gator LLC

Disclosed balance after: 9,900

F1 · price: This is the weighted average sales price representing 10,000 shares sold at prices ranging from $29.94 to $30.86 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F3 · ownership.nature: The Reporting Person is a managing member of Baby Gator LLC.

SEC source: 0001104659-20-105778 · a4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Baby Gator LLC

Disclosed balance after: 19,900

F3 · ownership.nature: The Reporting Person is a managing member of Baby Gator LLC.

SEC source: 0001104659-20-061859 · a4.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,790

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock. The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of the vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 12, 2020 for no consideration.

SEC source: 0001127430-19-000079 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,693

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the vesting date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2019, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-18-000078 · edgar.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by family LLC

Disclosed balance after: 20,000

F2 · price: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $15.57 to $15.59. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.

F3 · ownership.nature: The reporting person has sole voting control of the LLC, but shares ownership with certain family members.

SEC source: 0001127430-18-000078 · edgar.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by family LLC

Disclosed balance after: 11,205

F3 · ownership.nature: The reporting person has sole voting control of the LLC, but shares ownership with certain family members.

SEC source: 0001127430-18-000078 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by family LLC

Disclosed balance after: 10,000

F1 · price: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $16.31 to $16.40. The number of shares sold at each separate price will be made available to the SEC staff, the issuer or a security holder of the issuer upon request.

F3 · ownership.nature: The reporting person has sole voting control of the LLC, but shares ownership with certain family members.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 5

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 225,728

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.50 to $25.88, inclusive.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 4

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,936

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.89 to $26.40, inclusive.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 3

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,728

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.21 to $29.50, inclusive.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,134

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $28.82, inclusive.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,262

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.84 to $29.20, inclusive.

F7 · balance_after: The number of shares reflected here excludes 443 shares previously reported for which Dr. Sharoky does not have beneficial ownership.

SEC source: 0001127430-17-000046 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,171

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-18-000043 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,794

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock.